Literature DB >> 28899259

Delivery of HIV Antiretroviral Therapy Adherence Support Services by HIV Care Providers in the United States, 2013 to 2014.

John Weiser1, Linda Beer1, John T Brooks1, Kathleen Irwin1, Brady T West2, Christopher C Duke3, Garrett W Gremel3, Jacek Skarbinski1.   

Abstract

BACKGROUND: Little is known about clinicians' adoption of recommendations of the International Association of Providers of AIDS Care and others for supporting adherence to antiretroviral therapy (ART).
METHODS: We surveyed a probability sample of US HIV care providers to estimate the percentage offering 3 ART adherence support services to most or all patients and assessed the characteristics of providers offering all 3 services (comprehensive support) to most or all patients.
RESULTS: Almost all providers (95.5%) discussed ART adherence at every visit, 60.1% offered advice about tools to increase adherence, 53.5% referred nonadherent patients for supportive services, and 42.8% provided comprehensive support. Nurse practitioners were more likely to offer comprehensive support as were providers who practiced at Ryan White HIV/AIDS Program-funded facilities, provided primary care, or started caring for HIV-infected patients within 10 years.
CONCLUSION: Less than half of HIV care providers offered comprehensive ART adherence support. Certain subgroups may benefit from interventions to increase delivery of adherence support.

Entities:  

Keywords:  HIV provider; adherence guidelines; antiretroviral

Mesh:

Substances:

Year:  2017        PMID: 28899259      PMCID: PMC5662493          DOI: 10.1177/2325957417729754

Source DB:  PubMed          Journal:  J Int Assoc Provid AIDS Care        ISSN: 2325-9574


  24 in total

Review 1.  Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Authors:  Jane M Simoni; Ann E Kurth; Cynthia R Pearson; David W Pantalone; Joseph O Merrill; Pamela A Frick
Journal:  AIDS Behav       Date:  2006-05

2.  Qualifications, Demographics, Satisfaction, and Future Capacity of the HIV Care Provider Workforce in the United States, 2013-2014.

Authors:  John Weiser; Linda Beer; Brady T West; Christopher C Duke; Garrett W Gremel; Jacek Skarbinski
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

3.  Ryan White: an unintentional home builder.

Authors:  Michael S Saag
Journal:  AIDS Read       Date:  2009-05

4.  Access to specialty care and medical services in community health centers.

Authors:  Nakela L Cook; LeRoi S Hicks; A James O'Malley; Thomas Keegan; Edward Guadagnoli; Bruce E Landon
Journal:  Health Aff (Millwood)       Date:  2007 Sep-Oct       Impact factor: 6.301

5.  Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population.

Authors:  Jeffrey Rothman; Diane Rudnick; Marc Slifer; Bruce Agins; Karl Heiner; Guthrie Birkhead
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

6.  Quality of HIV care provided by nurse practitioners, physician assistants, and physicians.

Authors:  Ira B Wilson; Bruce E Landon; Lisa R Hirschhorn; Keith McInnes; Lin Ding; Peter V Marsden; Paul D Cleary
Journal:  Ann Intern Med       Date:  2005-11-15       Impact factor: 25.391

7.  Effect of a brief antiretroviral adherence intervention delivered by HIV care providers.

Authors:  Joel Milam; Jean L Richardson; Allen McCutchan; Susan Stoyanoff; Jony Weiss; Carol Kemper; Robert A Larsen; Harry Hollander; Penny Weismuller; Robert Bolan
Journal:  J Acquir Immune Defic Syndr       Date:  2005-11-01       Impact factor: 3.731

8.  Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.

Authors:  Karina M Berg; Alain Litwin; Xuan Li; Moonseong Heo; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2010-09-15       Impact factor: 4.492

9.  Implications of the Affordable Care Act for people with HIV infection and the Ryan White HIV/AIDS Program: what does the future hold?

Authors:  Jennifer Kates
Journal:  Top Antivir Med       Date:  2013 Sep-Oct

10.  A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems.

Authors:  Jeffrey H Samet; Nicholas J Horton; Seville Meli; Kim Dukes; Tara Tripps; Lisa Sullivan; Kenneth A Freedberg
Journal:  Antivir Ther       Date:  2005
View more
  5 in total

1.  Sustaining the HIV care provider workforce: Medical Monitoring Project HIV Provider Survey, 2013-2014.

Authors:  John Weiser; Guangnan Chen; Linda Beer; Daria Boccher-Lattimore; Wendy Armstrong; Ann Kurth; R Luke Shouse
Journal:  Health Serv Res       Date:  2019-07-01       Impact factor: 3.402

2.  Retention in HIV Care Among Participants in the Patient-Centered HIV Care Model: A Collaboration Between Community-Based Pharmacists and Primary Medical Providers.

Authors:  Kathy K Byrd; Felicia Hardnett; Patrick G Clay; Ambrose Delpino; Ron Hazen; Michael D Shankle; Nasima M Camp; Sumihiro Suzuki; Paul J Weidle
Journal:  AIDS Patient Care STDS       Date:  2019-01-16       Impact factor: 5.078

3.  Documenting Successes 30 Years After Passage of the Ryan White CARE Act: To the Editor.

Authors:  John Weiser; Antigone Dempsey; Paul Mandsager; R Luke Shouse
Journal:  J Assoc Nurses AIDS Care       Date:  2021 Mar-Apr 01       Impact factor: 1.809

4.  Why Do People Living with HIV Adhere to Antiretroviral Therapy and Not Comorbid Cardiovascular Disease Medications? A Qualitative Inquiry.

Authors:  Charles Muiruri; Isabelle P Sico; Julie Schexnayder; Allison R Webel; Nwora Lance Okeke; Christopher T Longenecker; Juan Marcos Gonzalez; Kelley A Jones; Sarah E Gonzales; Hayden B Bosworth
Journal:  Patient Prefer Adherence       Date:  2020-06-16       Impact factor: 2.711

5.  Trends in medication adherence in HIV patients in the US, 2001 to 2012: an observational cohort study.

Authors:  Bora Youn; Theresa I Shireman; Yoojin Lee; Omar Galárraga; Ira B Wilson
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 6.707

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.